Not all orbital inflammations in the COVID-19 era are due to mucormycosis – A case of orbital pseudotumour leading to vision loss
A 57-year-old male patient with type 2 diabetes mellitus who had survived severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease (COVID-19) presented with loss of vision in the right eye (RE) of 20-day duration. The patient had been diagnosed elsewhere with orbital mucormycosis and had...
Main Authors: | Lipika Mehra, Suprava Das, Pradeep Kumar Panigrahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Clinical and Scientific Research |
Subjects: | |
Online Access: | http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2023;volume=12;issue=2;spage=152;epage=154;aulast=Mehra |
Similar Items
-
Targeted orbital intervention in the management of sino-orbital mucormycosis cases
by: Rachna Meel, et al.
Published: (2024-10-01) -
The “Opercular” Approach to Orbital Reconstruction after Orbital Exenteration Following Rhino-Orbital-Cerebral Mucormycosis: A Novel Method
by: Bharatendu Swain, et al.
Published: (2025-02-01) -
Pseudotumour in a Haemophiliac with Inhibitor
by: Vasanthiamma Krishnannair Sreekala, et al.
Published: (2024-11-01) -
Orbital mucormycosis in an immunocompetent individual
by: P Badiee, et al.
Published: (2012-12-01) -
Expert opinion – Rhino-orbital-cerebral mucormycosis
by: Mohan Rajan, et al.
Published: (2021-01-01)